Amgen Held Liable for Patent Infringement in Landmark Mouse Antibody Case, Ordered to Pay $20.2 Million
A recent decision by a federal jury in Delaware has resulted in Amgen Inc. and its subsidiary, Teneobio Inc., being held liable for willful infringement of a mouse antibody patent owned by Harbour Antibodies BV and others. The jury awarded Harbour Antibodies BV $20.2 million, representing the full amount sought. The case has drawn attention…